SP
BNR

Sage Partners’s Burning Rock Biotech BNR Stock Holding History

Sage Partners’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,440
Closed -$1.66M – 2
2021
Q4 		$1.66M Buy
+17,440
New +$2.39M 12.82% 3

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sage Partners's BNR Position: Q1 2022 in Review

Sage Partners sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 17,440 shares — an estimated $1.66M sold.

Sage Partners first reported a position in BNR in Q4 2021 and held it in 1 quarter. The position peaked at $1.66M in Q4 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Sage Partners reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Sage Partners sold 17,440 Burning Rock Biotech shares in Q1 2022, an estimated $1.66M.
  • Sage Partners first reported a position in Burning Rock Biotech in Q4 2021 and held it in 1 quarter.
  • Sage Partners's Burning Rock Biotech position peaked at $1.66M in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Sage Partners's 13F filing for Q1 2022, filed 4 May 2022.